In vitro killing effect of moxifloxacin on clinical isolates of Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole

Antimicrob Agents Chemother. 2002 Dec;46(12):3997-9. doi: 10.1128/AAC.46.12.3997-3999.2002.

Abstract

The time-kill effect of moxifloxacin on 20 genetically distinct isolates of Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole was studied. The majority (80%) were killed by a concentration equivalent to four times the MIC; the MIC induced a transient decrease in bacterial counts at 4 h, followed by regrowth. No effect was detected in four isolates. These results merit further clinical consideration.

MeSH terms

  • Anti-Infective Agents / pharmacology*
  • Aza Compounds*
  • Dose-Response Relationship, Drug
  • Drug Resistance, Multiple, Bacterial / genetics
  • Fluoroquinolones*
  • Microbial Sensitivity Tests
  • Moxifloxacin
  • Quinolines*
  • Stenotrophomonas maltophilia / drug effects*
  • Stenotrophomonas maltophilia / genetics
  • Trimethoprim, Sulfamethoxazole Drug Combination / pharmacology*

Substances

  • Anti-Infective Agents
  • Aza Compounds
  • Fluoroquinolones
  • Quinolines
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Moxifloxacin